← Back to Search

Sedative

Dexmedetomidine for Sleep

Phase 4
Waitlist Available
Led By Anna Clebone, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will study the effect of dexmedetomidine on memory consolidation during sleep.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Perceptual Learning Protocol

Side effects data

From 2020 Phase 4 trial • 798 Patients • NCT02004613
57%
Clinically important hypotension
9%
Clinically important bradycardia
1%
infection
1%
stroke
1%
Atelectasis
1%
Hemorrhage
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Dexmedetomidine

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dexmedetomidine ArmExperimental Treatment1 Intervention
Dexmedetomidine: Administration of a 0.5 mcg/kg bolus followed by an infusion of 0.5-0.7 mcg/kg/hr, titrated up by 0.1 mcg every 1 minute until the subject spontaneously closes his or her eyes. When the subject spontaneously closes his or her eyes the infusion continues for 90 minutes from that point.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexmedetomidine
FDA approved

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
819,768 Total Patients Enrolled
14 Trials studying Sleep
1,499 Patients Enrolled for Sleep
Anna Clebone, MDPrincipal InvestigatorUniversity of Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the enrollment criteria for this clinical trial encompass individuals under 80 years of age?

"To be eligible for this trial, participants must have a chronological age between 18 to 35. If a patient is younger than 18 then there are 64 alternate trials they may take part in and if they are over the age of 65 there will 151 more suitable clinical studies available."

Answered by AI

Are participants being recruited to join this experiment?

"The information on clinicaltrials.gov attests that this medical trial is not actively recruiting patients, despite having first been posted in May 1st 2020 and last updated March 30th 2020. However, 253 other trials are presently welcoming volunteers to participate."

Answered by AI

What ailments have been addressed with Dexmedetomidine treatments?

"Dexmedetomidine can be utilized to ameliorate afflictions such as disease, ventilation issues, mechanical problems, and cyclic vomiting syndrome."

Answered by AI

Who would be the most suitable participants for this trial?

"To become part of this trial, individuals must be between 18 and 35 years old and display signs of sleep deprivation. In total, the team is looking for 20 participants."

Answered by AI

Could you provide an overview of research related to Dexmedetomidine?

"Presently, there are 110 active clinical trials exploring Dexmedetomidine with 23 of them in the culminating stage. Most investigations for this medication occur in Karachi, Sindh; however, 207 different sites have enrolled patients for these treatments."

Answered by AI

Has the FDA granted authorization for Dexmedetomidine?

"The safety of Dexmedetomidine is assessed to be a 3, as this drug has been approved and is thus in Phase 4 trials."

Answered by AI

What is the highest number of volunteer participants in this clinical trial?

"At the moment, this study is no longer recruiting participants. It was posted on May 1st 2020 and last updated on March 30th 2020. Alternately, there are currently 143 clinical trials related to sleep that are actively enrolling patients as well as 110 trials for Dexmedetomidine open for recruitment."

Answered by AI
~2 spots leftby Apr 2025